Jazz Pharmaceuticals

+$0.45 (+0.26%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: Xyrem, Xywav, Sunosi, Erwinaze, Vyxeos, Defitelio, and Zepzelca.

CEO
Bruce C. Cozadd
Employees
1,940
Headquarters
Dublin, Dublin
Founded
2003

JAZZ Key Statistics

Market Cap
10.85B
Price-Earnings Ratio
19.02
Dividend Yield
—
Average Volume
557.09K
High Today
$174.00
Low Today
$170.35
Open Price
$173.03
Volume
317.84K
52 Week High
$189.00
52 Week Low
$107.59

JAZZ News

Simply Wall StJul 25

Has Jazz Pharmaceuticals plc Stock's Recent Performance Got Anything to Do With Its Financial Health?

Jazz Pharmaceuticals' (NASDAQ:JAZZ) stock up by 4.3% over the past three months. As most would know, long-term fundamentals have a strong correlation with marke

JAZZ Earnings

$0.00
$1.47
$2.95
$4.42
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure